Ben Tre Pharmaceutical JSC (DBT) — Capital Reinvestment Ratio
Ben Tre Pharmaceutical JSC (DBT) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow (₫37.04 Billion) in capital expenditures (₫87.53 Million). See cash generation quality of Ben Tre Pharmaceutical JSC to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ben Tre Pharmaceutical JSC Capital Reinvestment Ratio (2016–2017)
This chart tracks Ben Tre Pharmaceutical JSC's Capital Reinvestment Ratio across 2 annual periods. Check Ben Tre Pharmaceutical JSC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ben Tre Pharmaceutical JSC (2016–2017)
Year-by-year Capital Reinvestment Ratio for Ben Tre Pharmaceutical JSC from 2016 to 2017. For live market cap and broader valuation context, see Ben Tre Pharmaceutical JSC market capitalisation.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.18x | ₫51.07 Billion | ₫9.02 Billion | ▲ +28.4% |
| 2016 | 0.14x | ₫32.71 Billion | ₫4.50 Billion | — |